Order Online! Now! Get your $50 coupon for online order.Order Online! Now! Get your $50 coupon for online order.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
ACC inhibitor treating NASH | Small molecule | Metabolic disease | NASH | IND | Global |
EED inhibitor | Small molecule | Oncology/Cancer | Solid tumor,Hematological malignancy | IND | Global |
DHODH inhibitor | Small molecule | Alimentary disease | inflammatory bowel disease | IND | Global |
Viscous Gel Temozolomide | Small molecule | Oncology/Cancer,Neurological disease | Glioblastoma | Phase I | Global except CIA |
Oxazolidone (new compounds) antibiotics | Small molecule | Infectious and parasitic diseases | gram-positive bacterial infections | IND | Global |
NF-kB inhibitor (Novel small molecule drug) for cancer cachexia | Small molecule | Oncology/Cancer | Cancer cachexia | PCC | Global |
HIF-PHs inhibitor for CKD and Renal anemia | Small molecule | Blood and Clotting disease | CKD,Renal anemia | Phase I | Global (except China) |
PI3K/mTOR dual inhibitor | Small molecule | Oncology/Cancer,Respiratory disease | IPF,solid tumor | Phase I | Global (except China) |
5-HT1F agonist | Small molecule | Neurological disease | Migraine | Phase I | Global |
Capsid Assembly Inhibitors for HBV | Small molecule | Infectious and parasitic diseases | HBV | Phase III | Global (except China) |
PI3Kδ inhibitor | Small molecule | Oncology/Cancer | Hematologic malignancies | Phase I | Global |
Capsid Assembly Inhibitors for HBV | Small molecule | Infectious and parasitic diseases | HBV | Phase I | Global (except China) |
RET high selective inhibitor | Small molecule | Oncology/Cancer | NSCLC,Medullary thyroid cancer,Thyroid cancer | Phase I | Global |
A SSRI & Partial 5-HT1A Agonist | Small molecule | Neurological disease | Depression | Phase III | Global |
sGC stimulator | Small molecule | Cardiovascular | PAH,CTEPH,HFrEF,CKD | Phase I | Global |
XO/URAT1 Dual target inhibitors for HUA | Small molecule | Metabolic disease | Hyperuricimia | Phase I | Global |
FXR Agonist | Small molecule | Metabolic disease | NASH | Phase II | Global |
SGLT2 inhibitor | Small molecule | Metabolic disease | Diabetes | Phase III | Global (except China) |
FXR Agonist | Small molecule | Metabolic disease | Diabetic kidney disease | Phase I | Global |
This web search service is supported by Google Inc.